Biospace taps London researchers on preclinical molecular imaging
Biospace Lab in Paris and the Centre for Advanced Biomedical Imaging at University College London (UCL) will collaborate on the development of real-time in vivo optical imaging applications and further development of the Biospace Lab PhotonImager Optima preclinical imaging platform.
The collaboration will bring together UCL imaging resarchers, Mark Lythgoe, PhD, director of Centre for Advanced Biomedical Imaging, and molecular probes, and Martin Pule, MB BCh, together with Biospace Lab to develop new molecular imaging technologies for biomedical research applications.
The initial focus will be on further method development in luminescence imaging and the integration of in vivo optical imaging with other in vivo imaging modalities, but it is hoped that the three-year collaboration will additionally support a range of biomedical research projects at UCL.
The collaboration will bring together UCL imaging resarchers, Mark Lythgoe, PhD, director of Centre for Advanced Biomedical Imaging, and molecular probes, and Martin Pule, MB BCh, together with Biospace Lab to develop new molecular imaging technologies for biomedical research applications.
The initial focus will be on further method development in luminescence imaging and the integration of in vivo optical imaging with other in vivo imaging modalities, but it is hoped that the three-year collaboration will additionally support a range of biomedical research projects at UCL.